What the first 10,000 patients with chronic urticaria have taught me: A personal journey

Journal of Allergy and Clinical Immunology

Volumn 123, Issue 3, 2009, Pages 713-717

  Kaplan, Allen P ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

angioedema; anti IgE receptor; antihistamine; corticosteroids; cyclosporine; histamine; Urticaria

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; CETIRIZINE; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; DIPHENHYDRAMINE; FEXOFENADINE; HISTAMINE; HYDROXYCHLOROQUINE; HYDROXYZINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; LEVOCETIRIZINE; LORATADINE; METHOTREXATE; PREDNISONE; SALAZOSULFAPYRIDINE; STEROID; TERFENADINE;

ALLERGIC RHINITIS; ANGIONEUROTIC EDEMA; AUTOIMMUNITY; CHRONIC URTICARIA; CLINICAL IMMUNOLOGY; CLINICAL RESEARCH; CLINICAL TRIAL; CORTICOSTEROID INDUCED MYOPATHY; DIABETES MELLITUS; DOSE RESPONSE; DRIVING ABILITY; DRUG DOSE INCREASE; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOD ALLERGY; HELICOBACTER PYLORI; HISTAMINE RELEASE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; LOW DRUG DOSE; MORNING DOSAGE; OBESITY; PATHOGENESIS; PRICK TEST; PRIORITY JOURNAL; SEDATION; SIDE EFFECT; SINGLE DRUG DOSE; SKIN MANIFESTATION; SKIN TEST; VASCULITIS; WEIGHT GAIN;

ALLERGENS; AUTOANTIBODIES; AUTOIMMUNITY; CHRONIC DISEASE; CYCLOSPORINE; GUIDELINES AS TOPIC; HISTAMINE ANTAGONISTS; HUMANS; HYDROXYZINE; IMMUNOSUPPRESSIVE AGENTS; METHOTREXATE; URTICARIA;

EID: 61849109861     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.10.050     Document Type: Editorial

References (51)

1. Shoemaker R. A search for the affective determinants of chronic urticaria. Psychosomatics 4 (1963) 125-132
2. Rees L. An etiological study of chronic urticaria and angioneurotic oedema. J Psychosom Res 2 (1957) 172
3. James J., and Warin R. An assessment of the role of Candida albicans and food yeasts in chronic urticaria. Br J Dermatol 84 (1971) 227-237
4. Juhlin L. Incidence of intolerance to food additives. Int J Dermatol 19 (1980) 548-551
5. Michaelsson G., and Juhlin L. Urticaria induced by preservatives and dye additives in food and drugs. Br J Dermatol 88 (1973) 525-532
6. James J., and Warin R. Chronic urticaria: the effect of aspirin. Br J Dermatol 82 (1970) 204-205
7. Zuberbier T., Chantraine-Hess S., Hartmann K., et al. Pseudoallergen-free diet in the treatment of chronic urticaria. A prospective study. Acta Derm Venereol 75 (1995) 484-487
8. Zuberbier T., Pfrommer C., Specht K., et al. Aromatic components of food as novel eliciting factors of pseudoallergic reactions in chronic urticaria. J Allergy Clin Immunol 109 (2002) 343-348
9. Guerra L., Rogkakou A., Massacane P., et al. Role of contact sensitization in chronic urticaria. J Am Acad Dermatol 56 (2007) 88-90
10. Di Lorenzo G., Pacor M., Mansueto P., et al. Food-additive-induced urticaria: a survey of 838 patients with recurrent chronic idiopathic urticaria. Int Arch Allergy Immunol 138 (2005) 235-242
11. Di Campli C., Gasbarrini A., Nucera E., et al. Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticaria. Dig Dis Sci 43 (1998) 1226-1229
12. Schnyder B., Helbling A., and Pichler W. Chronic idiopathic urticaria: natural course and association with Helicobacter pylori infection. Int Arch Allergy Immunol 119 (1999) 60-63
13. Gaig P., Olona M., Munoz Lejarazu D., et al. Epidemiology of urticaria in Spain. J Invest Allergol Clin Immunol 14 (2004) 214-220
14. Greaves M. Chronic idiopathic urticaria and Helicobacter pylori-not directly causative but could there be a link. Allergy Clin Immunol Int 13 (2001) 23-26
15. Leznoff A., and Sussman G. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol 84 (1989) 66-71
16. Kikuchi Y., Fann T., and Kaplan A. Antithyroid antibodies in chronic urticaria and angioedema. J Allergy Clin Immunol 112 (2003) 218
17. Hide M., Francis D., Grattan C., et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 328 (1993) 1599-1604
18. Fiebiger E., Maurer D., Holub H., et al. Serum IgG autoantibodies directed against the alpha chain of Fc epsilon RI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients?. J Clin Invest 96 (1995) 2606-2612
19. Kikuchi Y., and Kaplan A. Mechanisms of autoimmune activation of basophils in chronic urticaria. J Allergy Clin Immunol 107 (2001) 1056-1062
20. Gruber B., Baeza M., Marchese M., et al. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol 90 (1988) 213-217
21. Grattan C., Francis D., Hide M., et al. Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria. Clin Exp Allergy 21 (1992) 695-704
22. Kikuchi Y., and Kaplan A. A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol 109 (2002) 114-118
23. Soundararajan S., Kikuchi Y., Joseph K., et al. Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria. J Allergy Clin Immunol 115 (2005) 815-821
24. Greaves M., Plummer V., McLaughlan P., et al. Serum and cell bound IgE in chronic urticaria. Clin Allergy 4 (1974) 265-271
25. Kern F., and Lichtenstein L. Defective histamine release in chronic urticaria. J Clin Invest 57 (1976) 1369-1377
26. Vonakis B., Vasagar K., Gibbons S.J., et al. Basophil FcepsilonRI histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria. J Allergy Clin Immunol 119 (2007) 441-448
27. Luquin E., Kaplan A., and Ferrer M. Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli. Clin Exp Allergy 35 (2005) 456-460
28. Breneman D. Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria. Ann Pharmacol 30 (1996) 1075-1079
29. Simons F. Advances in H1-antihistamines. N Engl J Med 351 (2004) 2203-2217
30. Morgan M., and Khan D.A. Therapeutic alternatives for chronic urticaria: an evidence-based review, part 1. Ann Allergy Asthma Immunol 100 (2008) 403-412
31. McGirt L., Vasagar K., Gober L., et al. Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine. Arch Dermatol 142 (2006) 1337-1342
32. Cassano N., D'Argento V., Filotico R., et al. Low-dose dapsone in chronic idiopathic urticaria: preliminary results of an open study. Acta Derm Venereol 85 (2005) 254-255
33. Reeves G., Boyle M., Bonfield J., et al. Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation. Intern Med J 34 (2004) 182-186
34. Lang P.J. Sulfones and sulfonamides in dermatology today. J Am Acad Dermatol 1 (1979) 479-492
35. Grattan C., O'Donnell B., Francis D., et al. Randomized double-blind study of cyclosporin in chronic "idiopathic" urticaria. Br J Dermatol 143 (2000) 365-372
36. Toubi E., Blant A., Kessel A., et al. Low-dose cyclosporin A in the treatment of severe chronic idiopathic urticaria. Allergy 52 (1997) 312-316
37. Weiler J., Bloomfield J., Woodworth G., et al. Effects of fexofenadine, diphenhydramine, and alcohol on driving performance. A randomized, placebo-controlled trial in the Iowa driving simulator. Ann Intern Med 132 (2000) 354-363
38. Verster J., Volkerts E., van Oosterwijck A., et al. Acute and subchronic effects of levocetirizine and diphenhydramine on memory functioning, psychomotor performance, and mood. J Allergy Clin Immunol 111 (2003) 623-627
39. Ramaekers J. O'Hanlon J. Acrivastine, terfenadine and diphenhydramine effects on driving performance as a function of dose and time after dosing. Eur J Clin Pharmacol 47 (1994) 261-266
40. Verster J., and Volkerts E. Antihistamines and driving ability: evidence from on-the-road driving studies during normal traffic. Ann Allergy Asthma Immunol 92 (2004) 294-303
41. Finkle W., Adams J., Greenland S., et al. Increased risk of serious injury following an initial prescription for diphenhydramine. Ann Allergy Asthma Immunol 89 (2002) 244-250
42. Schweitzer P., Muehlbach M., and Walsh J. Sleepiness and performance during three-day administration of cetirizine or diphenhydramine. J Allergy Clin Immunol 94 (1994) 716-724
43. Bender B., Berning S., Dudden R., et al. Sedation and performance impairment of diphenhydramine and second-generation antihistamines: a meta-analysis. J Allergy Clin Immunol 111 (2003) 770-776
44. Verster J., de Weert A., Bijtjes S., et al. Driving ability after acute and sub-chronic administration of levocetirizine and diphenhydramine: a randomized, double-blind, placebo-controlled trial. Psychopharmacology 169 (2003) 84-90
45. Kaplan A. Chronic urticaria and angioedema. N Engl J Med 346 (2002) 175-179
46. Nguyen T., Shapiro D., George S., et al. Discovery of a novel member of the histamine receptor family. Mol Pharmacol 59 (2001) 427-433
47. Powell R., Du Toit G., Siddique N., et al. British Society for Allergy and Clinical Immunology (BSACI). BSACI guidelines for the management of chronic urticaria and angio-oedema. Clin Exp Allergy 37 (2007) 631-650
48. Zuberbier T., Bindslev-Jensen C., Canonica W., et al. EAACI/GA2LEN/EDF guideline: management of urticaria. Allergy 61 (2006) 321-331
49. Aversano M., Caiazzo P., Iorio G., et al. Improvement of chronic idiopathic urticaria with L-thyroxine: a new TSH role in immune response?. Allergy 10 (2005) 489-493
50. Kaplan A., Joseph K., Maykut R., et al. Treatment of chronic autoimmune urticaria with Omalizumab. J Allergy Clin Immunol 121 (2008) 227
51. Guber L., Sterba P., Eckman J., et al. Effect of anti IgE (omalizumab) in chronic idiopathic urticaria (CIU) patients. J Allergy Clin Immunol 5 (2008) 147